Cephalon announces fourth quarter 2002 results.
Cephalon Inc. reported a fourth-quarter 2002 profit of $140 million, or $2.46 per share. In the 2001 fourth quarter, the biotech firm lost $64.5 million, or $1.23 per share. Excluding a one-time gain, Cephalon said profit for the latest period was $23.3 million, or 41 cents per share. The company had been expected to earn 36 cents per share, according to the average estimate of analysts polled by Multex. Cephalon said fourth-quarter revenue rose to $144.3 million from $74.9 million.
